New Drugs Approved
New Breakthrough in Aggressive Breast Cancer
There’s new hope for patients with aggressive triple-negative breast cancer. Recent research shows that combining chemotherapy with the immunotherapy drug pembrolizumab before and after surgery can significantly improve survival rates. This breakthrough treatment, highlighted in the KEYNOTE-522 tria